Elliot Hershberg on LinkedIn
Elliot Hershberg - Not Boring - LinkedIn
I am a Scientist and Engineer with wide-ranging experience applying cutting-edge… · Experience: Not Boring · Education: Stanford University · Location: San ...
Elliot Hershberg on LinkedIn: An updated vision for The Century of ...
An updated vision for The Century of Biology I deeply appreciate all of the support so far. I'll continue to work hard to improve and ...
Elliot Hershberg on LinkedIn: Hub-and-Spoke Biotechs: Nimbus ...
I wrote about how Nimbus's fundamental business model innovation enabled them to make blockbuster drug deals—without selling their entire ...
Elliot Hershberg on LinkedIn: Programmable peptide-based ...
Programmable peptide-based degraders. Combo of a binder to an intracellular target—in this case, β-catenin—with an E3 ligase.
Elliot Hershberg's Post - Enveda Biosciences - LinkedIn
It's exciting to see one of Enveda's first programs officially enter the clinic! If you want to learn about how Viswa Colluru, ...
Elliot Hershberg on LinkedIn: We've learned fundamentally new ...
We've learned fundamentally new things about the computational universe by studying algorithms encoded in living systems.
Elliot Hershberg's Post - LinkedIn
Elliot Hershberg, a computational biologist, writer, and Biotech Partner at Not Boring, joins Karl Schmieder, MS MFA and Erum Azeez Khan to explore the ...
Elliot Hershberg on LinkedIn: New iPSC perturbation atlas Recent ...
New iPSC perturbation atlas Recent benchmarks have shown that we are still not very good at in silico gene perturbation prediction.
Elliot Hershberg on LinkedIn: Absolutely amazing: A transplantation ...
Absolutely amazing: A transplantation of chemically reprogrammed stem cells totally reversed a woman's case of Type I Diabetes (!
Elliot Hershberg on LinkedIn: Generating (Somewhat) New Biology ...
Last week, we saw headlines of a $1B Seed round for a new AI biotech startup (!!), and AI-generated CRISPR proteins.
Elliot Hershberg on LinkedIn: Can't get this recent quote out of my ...
Say what you will about ARCH's strategy, but this is awesome. We need more biotech investors with this type of internal conviction!
The Century of Biology | Elliot Hershberg | Substack - LinkedIn
Scientist | Cancer & Infection Immunology | Writer | Community Builder | Mentor -iGEM, TKS | Curious- Innovation & Funding Mechanisms. 1y.
Elliot Hershberg on LinkedIn: What's particularly special about the ...
Elliot Hershberg's Post ... What's particularly special about the new diabetes data (restoring insulin production with a stem cell transplant) is ...
Elliot Hershberg posted on the topic | LinkedIn
A scientologist-led (even more contrarian than scientist-led!) startup appears to have surpassed Keytruda—one of the highest-grossing drugs ...
Elliot Hershberg's Post - On biotech platform strategy - LinkedIn
On biotech platform strategy For biotech founders and investors, not all types of risk are the same. Opinions vary, but three major ...
Elliot Hershberg on LinkedIn: Observation from >1 year thinking ...
Observation from >1 year thinking really hard about investing: I care way more about *trajectory* vs. *background* Difference: I'm more ...
Elliot Hershberg on LinkedIn: Four of my favorite BioML preprints ...
Four of my favorite BioML preprints from this week: 1. One-shot design of protein binders—achieving nanomolar affinity without any experiments ...
Elliot Hershberg on LinkedIn: I know it sounds like buzzword bingo ...
I'm really glad to be in biotech in the era where people are using ML to predict the effects of epigenome editing and to automate the design of new CRISPR ...
Elliot Hershberg's Post - LinkedIn
Looking forward to another great SynBioBeta this year! Hope to see you there.
Elliot Hershberg on LinkedIn: Awesome news for the KdT Ventures ...
$100M+ to support science-driven companies. In my time in investing, they are one of the smartest—and kindest—teams I've come across ...